651 filings
Page 19 of 33
8-K/A
di97 o8hfo
5 Aug 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
86o4tks ahh0s
4 Aug 11
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2011 and Provides Update on Development Activities
12:00am
8-K
hj82fe9kitcwpsgek
2 Jun 11
Departure of Directors or Certain Officers
12:00am
8-K
ths698
9 May 11
Results of Operations and Financial Condition
12:00am
ARS
auvqmmctt2zudcw9
29 Apr 11
Annual report to shareholders
12:00am
8-K
f0op9dt
10 Mar 11
Results of Operations and Financial Condition
12:00am
8-K
hhuy5 d545
5 Jan 11
Departure of Directors or Certain Officers
12:00am
POS AM
fndki
3 Dec 10
Prospectus update (post-effective amendment)
12:00am
EFFECT
pkd083c8 6a
3 Dec 10
Notice of effectiveness
12:00am
8-K
o2d czw6jc8
8 Nov 10
OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer
12:00am
8-K
hs80bwop
4 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
f6qqpd135d4nk f5waj
22 Oct 10
OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering
12:00am
8-K
ncr0 eeqihqv
19 Oct 10
OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
12:00am
424B5
vk533nnfu rwbpljg
19 Oct 10
Prospectus supplement for primary offering
12:00am
8-K
ys2z42yj9qjnc
18 Oct 10
OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering
12:00am